PERSON – Page 8

BridgeBio’s Attruby Gains FDA Approval, Challenging Pfizer’s Tafamidis in ATTR-CM Treatment

2 months ago talkbio0Tagged Acoramidis, Approved, ATTR-CM, Attruby, BridgeBio, Cardiomyopathies, Pfizer, Prealbumin, Stabilizer - function, tafamidis, United States Food and Drug Administration

Attruby, acoramidis, BridgeBio, ATTR-CM, tafamidis, Pfizer, FDA approval, transthyretin stabilizer, cardiomyopathy

Trump’s Healthcare Nominees Pledge to Divest Industry Investments Amid Controversy

2 months ago talkbio0Tagged Bhattacharya, healthcare appointments, Industry, Jay, Jr., Mehmet, Myasthenic Syndromes, Congenital, NIH, NIH Mouse, ounce, ties, Transplant Registry Unified Management Program

Trump administration, healthcare appointments, NIH, CMS, divestment, industry ties, Jay Bhattacharya, Mehmet Oz, Robert F. Kennedy Jr.

Pfizer’s European Manufacturing Vulnerable to Potential US Tariffs, CEO Warns

2 months ago talkbio0Tagged Albert, Bourla, chain disruption, Drug Industry, European (ethnic group), Manufacturing, Pfizer, Tension, TNFRSF19 gene, U.S.

Pfizer, Albert Bourla, European manufacturing, US tariffs, pharmaceutical industry, trade tensions, supply chain disruption

RFK Jr. Backtracks on Vaccine Pledge, Announces Review of Childhood Immunization Schedule

2 months ago talkbio0Tagged CHARGE Syndrome, childhood vaccine schedule, Confirmation, Disease Outbreaks, measles, public health medicine (field), Robert F. Kennedy, Secretary, Senate

Robert F. Kennedy Jr., HHS Secretary, childhood vaccine schedule, review, controversy, public health, measles outbreak, Senate confirmation

FDA Approves Ono’s Romvimza for Rare Joint Tumor, Challenging Daiichi Sankyo’s Turalio

2 months ago talkbio0Tagged Approved, CSF1, CSF1 gene, Daiichi, Dosage Forms, Fibrous histiocytoma of tendon sheath, Giant Cell Tumors, Inhibitor, Joint Tumor, Romvimza, Sankyo, tenosynovial, Turalio, United States Food and Drug Administration, Vimseltinib

Romvimza, vimseltinib, tenosynovial giant cell tumor (TGCT), Ono Pharmaceutical, FDA approval, Daiichi Sankyo, Turalio, CSF1 inhibitor, rare joint tumor

Arcus Biosciences Advances Promising Kidney Cancer Drug Casdatifan After Gilead Opts Out

2 months ago talkbio0Tagged Arcus, casdatifan, cell renal cell carcinoma, Clinical Trials, Conventional (Clear Cell) Renal Cell Carcinoma, HIF-2a, Inhibitor, Malignant neoplasm of kidney

Arcus Biosciences, casdatifan, HIF-2a inhibitor, kidney cancer, clear cell renal cell carcinoma (ccRCC), Gilead Sciences, clinical trial data, $150 million stock offering

Trump Establishes Make America Healthy Again Commission to Combat Childhood Chronic Diseases

2 months ago talkbio0Tagged CHARGE Syndrome, Chronic disease, Commission, disease prevention, MAHA, public health medicine (field), Robert F. Kennedy Jr., Secretary

MAHA Commission, Robert F. Kennedy Jr., childhood chronic diseases, HHS Secretary, Executive Order, public health, chronic illness, disease prevention